Characterization
of Xp21 distal to Duchenne muscular dystrophy (DMD) in the region containing the genes for adrenal hypoplasia congenita (AHC) and glycerol kinase deficiency (GKD) has been limited due to a paucity of probes.
Two 
INTRODUCTION
Analyses of DNA from patients with Xp21 contiguous gene syndromes have allowed us to order (Xpter-ten) the following loci: adrenal hypoplasia congenita (AHC), glycerol kinase (GK), and Duchenne muscular dystrophy (DMD) (reviewed in McCabe, 1989) . Characterization of Xp21 distal to DMD has been limited due to a paucity of probes.
This project was initiated to improve the mapping information and to develop "sequence-tagged sites" (STSs) (Olson et al., 1989) for the Xp21 region distal to DMD. Experience with DMD has established the diagnostic value of this information, particularly through multiplexing of individual polymerase chain reaction (PCR) amplifications (Chamberlain et al., 1988) . Extending these molecular genetic diagnostic capabilities has considerable clinical importance because of the risk of death due to Addisonian crisis (Kohlschiitter et al., 1987) among patients with untreated AHC. We report the localization of three probes to this region and the acquisition of sequence information from each. Generation of individual PCR amplifications and a triplex reaction has improved mapping and diagnosis in Xp21 distal to DMD.
MATERIALS AND METHODS

Patients. A chart indicating
the phenotypes of the patients and a summary of the extent of their deletions is shown in Fig. 1 . The phenotype designations adapted for microdeletions in this region will be used (McCabe, 1989 et al., 1987; Kohlschiitter, 1987) . CM was reported with AGD (Francke etal., 1987; Towbin et al., 1989; McCabe et al., 1989) . YB was diagnosed with AGK (Francke et al., 1987; Marlhens et al., 1987 Markers.
Of the previously described probes (Fig. l) , C7 is the most centromeric among Ll-4 (DXS68). B24 (DXS67), and C7 (DXS28) (Towbin et al., 1990) . The order of Ll-4 and B24 has been established using fluorescence in situ hybridization (Trask et al., 1992) and through yeast artificial chromosome (YAC) contigs (Walker et al., 1991 
RESULTS
Eighteen patients were characterized, and the results are shown in Fig. 1 . The YHX39R primer pair amplified a 98-bp fragment, DXS727, which mapped the same as YHX39L by Southern blot in the patients (Fig. 1) . The PCR results are shown in Fig. 2 . The interval between C7 (DXS28) and YHX39R (DXS727) contained the telomeric deletion breakpoints of several patients, including MC, CC, TJ, MK1753, CM, IY, and YB.
The presence of the DXS319 locus in the patients was determined by Southern hybridization with the probe pQST59M4(b) (Fig. 1) . The QST59 (DXS319) primers amplified a 229-bp STS, and the PCR results are shown in Fig. 2 . The QST59 STS defined a difference in the telomeric deletion breakpoints between patients TM and LB108: the telomeric deletion breakpoint for both patients was centromeric of YHX39 (DXS727), but only the telomeric deletion breakpoint for TM was centromerit of QST59, presumably between DXS319 and the centromeric extent of AHC.
FTl was sequenced, and primers that amplified a 283-bp STS (DXS726) were designed. The PCR results are shown in Fig. 2 .
To improve the diagnostic efficiency for diagnosis of patients with deletions involving this region, the three sets of PCR primers were combined into one multiplex reaction (Fig. 2) . The results were identical to those seen in the uniplex reactions (data not shown).
DISCUSSION
Patients with deletions who have AHC, but not GKD or DMD, have been described (Yates et al., 1987; and DW this paper) . These patients have also had developmental delay, in contrast to those with isolated AHC and no detectable deletions (TP,SF) who are developmentally normal and presumably have point or other small mutations. Patients with GKD and DMD who do not have AHC (Davies et al., 1988) and patients who have AHC and GKD but not DMD (Marlhens et al., 1987 , Franke et al., 1987  and RR this paper) have been described. Analyses of DNA from these patients with Xp21 contiguous gene syndromes have allowed the loci to be ordered (Xpter-ten):
AHC, GK, and DMD (reviewed in McCabe, 1989 Three markers were localized in Xp21 distal to DMD, between DXS28 (C7) and DMD. The PCR results for these markers, YHX39, QST59, and FTl, confirm the mapping results obtained by Southern blotting. Analysis of DNA from patients mapped these probes (Fig. 3) with deletion breakpoints in each of these intervals: DXS28 (C7) to YHX39, YHX39 to QST59, QST59 to AHC, and GK to FTl. Therefore, the genes for AHC and GK are flanked by the markers QST59 and FTl. YHX39 and QST59 are located between DXS28 (C7) and AHC, with YHX39 telomeric to QST59. FTl is between GK and DMD.
One other probe has been mapped to the region between DXS28 (C7) and DMD. This probe, JC-1, was cloned from the junction fragment of a patient with
Results of multiplex PCR amplification of patient DNAs using primers 91-92,91-93,3568,3569,3328, and 3329 . The top band is FTl (283 bp), the middle band is QST59 (229 bp), and the bottom band is YHX39R
(98 bp).
DMD and GK, but not AHC (Love et al., 1990) . JC-1 maps to the region between the centromeric extent of the AHC and the centromeric extent of the GK genes (Love et al., 1990) . The patient deletion breakpoints and the new probes (YHX39, QST59, and FTl) can be used as additional landmarks to expand the map in the region (Fig. 3) . The orientation of YHX39R and YHX39L is determined by YAC mapping data (Worley et al., in preparation) . When a complete YAC contig is developed for this region, all of the patient deletion breakpoints will be separated unless there is some feature of the DNA that encourages chromosome rearrangement.
The patient deletion breakpoints define intervals that indicate more precisely the location of the genes in the region (Fig. 3) . For instance, patient TM has a deletion that includes or interrupts the AHC gene and extends toward the centromere. DW has a deletion that includes or interrupts the AHC gene and extends toward the telomere, but does not interrupt the GK gene. Therefore, some or all of the interval between these two breakpoints must be within the AHC gene. Likewise, the interval between the DW centromeric deletion breakpoint (or the probe JC-1) and the YB and RR centromeric deletion breakpoints contains all or part of the GK gene.
The patient information and the new markers are important in terms of the diagnostic abilities in the region. The three new STSs have been combined into a multiplex PCR reaction for DNA diagnosis. Several patients have had phenotypes suggesting the extension of deletions in a telomeric direction beyond DMD, but previously available markers were unable to provide molecular genetic evidence to support this. The markers re- ported here provide that evidence for patients MC, CC, TJ, MK1753, CM, IY, LB108, and TM. In addition, one patient, YB, with AGK (AHC, GKD) whose DNA had not shown a deletion with any previous probes, was shown to have a deletion by these markers.
In conclusion, we have characterized three probes (YHX39, QST59, and FTl) and their corresponding STSs that map between DXS28 (C7) and DMD as shown. This study identified a new marker (QST59), which is the closest flanking marker to AHC. This has enabled better definition of the breakpoint for patient LB108, which flanks and significantly narrows the interval in which the AHC gene is located. The fact that both QST59 and YHX39 identify a previously undetectable deletion in the patient YB confirms that QST59 is significantly closer to AHC than previously available probes. This indicates the value of these new markers, both for the diagnosis of AGD and for the cloning of the AHC and GK genes. 
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